DELEC1 (Gene)

Entrez:50514

Description:deleted in esophageal cancer 1

The function of this gene is not known. This gene is located in a region commonly deleted in esophageal squamous cell carcinomas. Gene expression is reduced or absent in these carcinomas and thus this is a candidate tumor suppressor gene for esophageal squamous cell carcinomas. [provided by RefSeq, Jul 2008]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View DELEC1's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with DELEC1.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using DELEC1.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for DELEC1.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with DELEC1.

Results found

Linked to

	Label	Description
	GSE138789 metformin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 11 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147876 GSE147877 enzalutamide MR42D 4 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 11 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 5 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE197555 trametinib A-549 NCI-H460 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE145960 GSE145962 bms 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE148200 gemcitabine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE138789 metformin 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE216043 cisplatin 11 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE147876 GSE147877 enzalutamide MR42D 4 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE216043 cisplatin 11 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE226249 pirfenidone HL 5 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE197555 trametinib A-549 NCI-H460 0 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE145960 GSE145962 bms 3 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE148200 gemcitabine 1 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE216043 cisplatin 3 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.